Andrea Leung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrea Leung has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Allison Kranyak
Department of Dermatology, University of California San Francisco, San Francisco, USA
2 shared publications - John Koo
Psoriasis and Skin Treatment Center, University of California, San Francisco, San Francisco, USA
2 shared publications - Wilson Liao
Department of Dermatology, University of California, San Francisco, San Francisco, California, USA
2 shared publications - Alina S. Feng
Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA
1 shared publication - Amélie Spangenberg
A. Spangenberg, MBBS, Department of Dermatology, University of California San Francisco, San Francisco, California, USA
1 shared publication - Anneliese Taylor
UCSF Benioff Children’s Hospital Oakland, Department of Orthopaedic Surgery, 747 52nd Street, Oakland, CA 94609, USA
1 shared publication
Latest Publications
- Open Access
- 16 June 2026
- Published by Springer Nature in CNS Drugs
- Vol. 40 (8) , 1029-1036
Managing Dermatologic Delusional Disorders: A US Psychodermatology Perspective for Clinicians
Dermatological delusional disorders, such as delusional infestation (DI), are a unique type of psychosis in which the patient experiences specific delusions, such as parasites or inorganic materials that come out of their skin. Originally, this type of "encapsulated psychosis" was thought to be unresponsive to antipsychotic agents. However, over the past half a century, several medications with antipsychotic properties have been found to be effective in the treatment of these conditions in the USA, especially pimozide and risperidone. Despite effective treatments, several challenges may arise for clinicians in successfully treating patients with these conditions. These challenges include selecting an efficacious medication and skillfully practicing diplomacy and empathy while guiding patients toward effective management. Navigating interactions with patients with DI and their frequent denial of a psychiatric component to their condition often poses additional challenges to patient-provider rapport and proper and timely management. In the USA, many patients with DI are opposed to trying the conventional approach of psychiatric care and immediate trial of antipsychotic medications. This manuscript represents a single-center psychodermatology perspective on managing dermatologic delusional disorders. This article synthesizes clinical experience from a US clinic and situates that experience within the available evidence. High-quality comparative data are limited. Therefore, this paper highlights pragmatic engagement strategies, pharmacotherapy principles, essential safety monitoring, and research priorities. Experience-based recommendations are clearly labeled as such.
- 16 June 2026
- Published by Springer Nature in CNS Drugs
- Vol. 40 (8) , 1029-1036
Open AccessManaging Dermatologic Delusional Disorders: A US Psychodermatology Perspective for Clinicians
Dermatological delusional disorders, such as delusional infestation (DI), are a unique type of psychosis in which the patient experiences specific delusions, such as parasites or inorganic materials that come out of their skin. Originally, this type of "encapsulated psychosis" was thought to be unresponsive to antipsychotic agents. However, over the past half a century, several medications with antipsychotic properties have been found to be effective in the treatment of these conditions in the USA, especially pimozide and risperidone. Despite effective treatments, several challenges may arise for clinicians in successfully treating patients with these conditions. These challenges include selecting an efficacious medication and skillfully practicing diplomacy and empathy while guiding patients toward effective management. Navigating interactions with patients with DI and their frequent denial of a psychiatric component to their condition often poses additional challenges to patient-provider rapport and proper and timely management. In the USA, many patients with DI are opposed to trying the conventional approach of psychiatric care and immediate trial of antipsychotic medications. This manuscript represents a single-center psychodermatology perspective on managing dermatologic delusional disorders. This article synthesizes clinical experience from a US clinic and situates that experience within the available evidence. High-quality comparative data are limited. Therefore, this paper highlights pragmatic engagement strategies, pharmacotherapy principles, essential safety monitoring, and research priorities. Experience-based recommendations are clearly labeled as such.
- Open Access
- 11 May 2026
- Published by Dermsquared in SKIN The Journal of Cutaneous Medicine
- Vol. 10 (3) , 3072-3081
Patient Characteristics and Treatment Approaches in Delusional Infestation Across Two Medical Centers: A Retrospective Study
Background: Delusional Infestation (DI) is a psychiatric disorder marked by persistent, false belief of infestation despite medical evidence to the contrary. Large-scale research on DI is limited, with only one population-based study to date. DI remains poorly understood and difficult to manage. Methods: We conducted a multicenter retrospective chart review of adult outpatients seen in tertiary dermatology clinics at the University of Michigan and University of California, San Francisco between January 2021 and May 2024. Patients were identified using relevant ICD codes, and eligibility was confirmed by manual review for DSM-5 criteria for DI. Key clinical and demographic data were extracted, and relevant risk was calculated using national prevalence data from NAMI and SAMHSA. Results: We identified 155 patients with DI; most were female (79%), non-Hispanic (94%), and white (73%). Mean age of onset was 54 years, with a three-year diagnostic delay. Delusions commonly involved parasites (25%) or bugs/insects (27%). Diagnostic evaluations included skin biopsy (34%) and skin scrapings (15%), with significant variation between centers. Substance use and psychiatric comorbidities were prevalent, with elevated relative risks compared to population data. Treatments most often involved antiparasitic agents, pimozide, or second-generation antipsychotics; pimozide was associated with the highest rate of improvement Conclusions: DI primarily affects middle-aged female and is marked by delayed diagnosis, frequent substance use, and psychiatric comorbidities. Despite varied diagnostic approaches, treatment outcomes remain poor. Multidisciplinary care and standardized protocols are needed to improve management and outcomes.
- 11 May 2026
- Published by Dermsquared in SKIN The Journal of Cutaneous Medicine
- Vol. 10 (3) , 3072-3081
Open AccessPatient Characteristics and Treatment Approaches in Delusional Infestation Across Two Medical Centers: A Retrospective Study
Background: Delusional Infestation (DI) is a psychiatric disorder marked by persistent, false belief of infestation despite medical evidence to the contrary. Large-scale research on DI is limited, with only one population-based study to date. DI remains poorly understood and difficult to manage. Methods: We conducted a multicenter retrospective chart review of adult outpatients seen in tertiary dermatology clinics at the University of Michigan and University of California, San Francisco between January 2021 and May 2024. Patients were identified using relevant ICD codes, and eligibility was confirmed by manual review for DSM-5 criteria for DI. Key clinical and demographic data were extracted, and relevant risk was calculated using national prevalence data from NAMI and SAMHSA. Results: We identified 155 patients with DI; most were female (79%), non-Hispanic (94%), and white (73%). Mean age of onset was 54 years, with a three-year diagnostic delay. Delusions commonly involved parasites (25%) or bugs/insects (27%). Diagnostic evaluations included skin biopsy (34%) and skin scrapings (15%), with significant variation between centers. Substance use and psychiatric comorbidities were prevalent, with elevated relative risks compared to population data. Treatments most often involved antiparasitic agents, pimozide, or second-generation antipsychotics; pimozide was associated with the highest rate of improvement Conclusions: DI primarily affects middle-aged female and is marked by delayed diagnosis, frequent substance use, and psychiatric comorbidities. Despite varied diagnostic approaches, treatment outcomes remain poor. Multidisciplinary care and standardized protocols are needed to improve management and outcomes.
- 5 August 2025
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 52 (Suppl 3) , 55-58
MHC-I-opathy: A Unified Concept for the Etiology of Several Major Histocompatibility Complex–Associated Conditions Including Psoriasis and Psoriatic Arthritis
At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting, Drs. Dennis McGonagle and Wilson Liao discussed “MHC-I-opathies,” a class of immune-mediated diseases genetically associated with major histocompatibility complex class I (MHC-I) and class I peptide processing. MHC-I-opathies demonstrate epistatic interactions, genetic associations, and immunopathology that are distinct from classic B cell and autoantibody-driven autoimmune diseases. Investigations into the pathomechanisms of MHC-I-opathies have revealed a blend of tissue-specific innate immunity and CD8 T cell responses. Several functional pathomechanisms by which MHC-I molecules increase psoriasis (PsO) susceptibility were presented by McGonagle and Liao, and there were multiple associations within the HLA-C locus. Antigen presentation to T cells, HLA regulation of natural killer cells and CD8 T cells through killer immunoglobulin-like receptors, and HLA regulation of dendritic cells through leukocyte immunoglobulin-like receptors were discussed. Interestingly, MHC-I associations are not only linked to excessive inflammation in MHC-I-opathies but also to the spontaneous suppression of infection (eg, HIV-1 elite controllers). This striking prominence of MHC-I in PsO and antiviral immunity provides insight into why autoimmune alleles are maintained in the human genome and how protective antiviral pathways may be linked to aberrant activation of MHC-I-opathies. Outside of spinal inflammation in HLA-B27–positive axial psoriatic arthritis (PsA), the basis for MHC-I genetics in PsA remains less clear and is at least partly linked to greater PsA heterogeneity. Understanding the contribution of MHC-I in PsO and PsA may have important implications for therapy development.
- 5 August 2025
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 52 (Suppl 3) , 55-58
MHC-I-opathy: A Unified Concept for the Etiology of Several Major Histocompatibility Complex–Associated Conditions Including Psoriasis and Psoriatic Arthritis
At the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting, Drs. Dennis McGonagle and Wilson Liao discussed “MHC-I-opathies,” a class of immune-mediated diseases genetically associated with major histocompatibility complex class I (MHC-I) and class I peptide processing. MHC-I-opathies demonstrate epistatic interactions, genetic associations, and immunopathology that are distinct from classic B cell and autoantibody-driven autoimmune diseases. Investigations into the pathomechanisms of MHC-I-opathies have revealed a blend of tissue-specific innate immunity and CD8 T cell responses. Several functional pathomechanisms by which MHC-I molecules increase psoriasis (PsO) susceptibility were presented by McGonagle and Liao, and there were multiple associations within the HLA-C locus. Antigen presentation to T cells, HLA regulation of natural killer cells and CD8 T cells through killer immunoglobulin-like receptors, and HLA regulation of dendritic cells through leukocyte immunoglobulin-like receptors were discussed. Interestingly, MHC-I associations are not only linked to excessive inflammation in MHC-I-opathies but also to the spontaneous suppression of infection (eg, HIV-1 elite controllers). This striking prominence of MHC-I in PsO and antiviral immunity provides insight into why autoimmune alleles are maintained in the human genome and how protective antiviral pathways may be linked to aberrant activation of MHC-I-opathies. Outside of spinal inflammation in HLA-B27–positive axial psoriatic arthritis (PsA), the basis for MHC-I genetics in PsA remains less clear and is at least partly linked to greater PsA heterogeneity. Understanding the contribution of MHC-I in PsO and PsA may have important implications for therapy development.
- Open Access
- 1 February 2024
- Published by EDP Sciences in SICOT-J
- Vol. 10, 6
Peer-reviewed publications in orthopaedic surgery from lower income countries: A comparative analysis
Introduction: Musculoskeletal (MSK) disease is a substantial global burden, especially in lower income countries. However, limited research has been published on MSK health by scholars from these countries. We aimed to study the distribution of authorships, including trends in peer-reviewed orthopaedic publications based on each author’s affiliated institution’s country income status. Methods: Based on a bibliometric search, 119 orthopaedic-related journals were identified using the Journal Citation Reports database. Details of all scientific articles published in these journals between 2012 and 2021 were used to study trends and association between each of the author’s affiliated institution’s country income status, using the World Bank Classification. Results: Of the 133,718 unique articles, 87.6% had at least one author affiliation from a high-income country (HIC), 7.0% from an upper-middle income country (UMIC), 5.2% from a lower-middle income country (LMIC), and 0.2% from a low-income country (LIC). Overall, these articles were cited 1,825,365 times, with 92.5% of citations from HIC-affiliated authors and < 0.1% from LIC-affiliated authors. Over the 10-year study period, HIC-affiliated articles demonstrated the largest increase in the number of publications (9107–14,619), compared to UMIC-affiliated (495–1214), LMIC-affiliated (406–874), and LIC-affiliated articles (4–28). Conclusions: There are large and persistent disparities in orthopaedic research publications based on the country income status of the author’s affiliated institution, especially in the higher impact orthopaedic journals. Efforts should be made to increase opportunities for scholars from LICs and LMICs to publish their research in high-impact orthopaedic journals.
- 1 February 2024
- Published by EDP Sciences in SICOT-J
- Vol. 10, 6
Open AccessPeer-reviewed publications in orthopaedic surgery from lower income countries: A comparative analysis
Introduction: Musculoskeletal (MSK) disease is a substantial global burden, especially in lower income countries. However, limited research has been published on MSK health by scholars from these countries. We aimed to study the distribution of authorships, including trends in peer-reviewed orthopaedic publications based on each author’s affiliated institution’s country income status. Methods: Based on a bibliometric search, 119 orthopaedic-related journals were identified using the Journal Citation Reports database. Details of all scientific articles published in these journals between 2012 and 2021 were used to study trends and association between each of the author’s affiliated institution’s country income status, using the World Bank Classification. Results: Of the 133,718 unique articles, 87.6% had at least one author affiliation from a high-income country (HIC), 7.0% from an upper-middle income country (UMIC), 5.2% from a lower-middle income country (LMIC), and 0.2% from a low-income country (LIC). Overall, these articles were cited 1,825,365 times, with 92.5% of citations from HIC-affiliated authors and < 0.1% from LIC-affiliated authors. Over the 10-year study period, HIC-affiliated articles demonstrated the largest increase in the number of publications (9107–14,619), compared to UMIC-affiliated (495–1214), LMIC-affiliated (406–874), and LIC-affiliated articles (4–28). Conclusions: There are large and persistent disparities in orthopaedic research publications based on the country income status of the author’s affiliated institution, especially in the higher impact orthopaedic journals. Efforts should be made to increase opportunities for scholars from LICs and LMICs to publish their research in high-impact orthopaedic journals.